All test packages
Prenatal Care

Geno NIPT 3

Screens for three common chromosomal conditions: Down syndrome (T21), Edwards syndrome (T18) and Patau syndrome (T13).

1 testsTurnaround: 2–4 days

Screens for three common chromosomal conditions: Down syndrome (T21), Edwards syndrome (T18) and Patau syndrome (T13).

NIPT is a screening test, not a diagnostic test. Please seek professional advice about eligibility and the meaning of your result.

Understanding NIPT screening

NIPT analyzes cell-free DNA in maternal blood, including DNA originating from the placenta, to assess the chance of selected fetal chromosome conditions. It uses a maternal blood sample without directly sampling the fetus. Packages differ in scope; choose after counseling, not simply by the number of items.

Package screening scope

T21 · T18 · T13

Three common trisomies

What do these items mean?

Three common trisomies

Assesses the chance of Down syndrome (an extra chromosome 21), Edwards syndrome (an extra chromosome 18) and Patau syndrome (an extra chromosome 13). These are three chromosome-number conditions commonly included in prenatal screening.

From blood sample to result counseling

Counseling & maternal blood sample
1

Counseling & maternal blood sample

Confirm gestational age, history and package suitability with your clinician before sampling.

DNA analysis
2

DNA analysis

The laboratory analyzes the sample within the chosen panel. Result turnaround: 2–4 days.

Results & follow-up counseling
3

Results & follow-up counseling

Your clinician explains the risk, the result’s limitations and any follow-up needed.

Results & important limitations

Low risk

Makes the screened conditions less likely but does not exclude them. Continue recommended prenatal care and ultrasound; NIPT does not assess every genetic condition or birth defect.

High risk

Does not diagnose an affected fetus. Seek genetic counseling and discuss diagnostic testing such as chorionic villus sampling or amniocentesis before important medical decisions.

No result / nonreportable result

Does not mean low risk. Your clinician will assess whether repeat sampling, ultrasound or diagnostic testing is appropriate.

Clinical references: SMFM #74 · ACOG

Included tests

Test name
Geno NIPT 3 non-invasive prenatal screening